| Banff 07 classification of renal allograft pathology: updates and future directions K Solez, RB Colvin, LC Racusen, M Haas, B Sis, M Mengel, PF Halloran, ... American journal of transplantation 8 (4), 753-760, 2008 | 2312 | 2008 |
| Banff’05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (’CAN’) K Solez, RB Colvin, LC Racusen, B Sis, PF Halloran, PE Birk, ... American Journal of Transplantation 7 (3), 518-526, 2007 | 1401 | 2007 |
| The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative … M Haas, A Loupy, C Lefaucheur, C Roufosse, D Glotz, D Seron, ... American Journal of Transplantation 18 (2), 293-307, 2018 | 1029 | 2018 |
| Banff’09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups B Sis, M Mengel, M Haas, RB Colvin, PF Halloran, LC Racusen, K Solez, ... American journal of transplantation 10 (3), 464-471, 2010 | 935 | 2010 |
| Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure RS Gaston, JM Cecka, BL Kasiske, AM Fieberg, R Leduc, FC Cosio, ... Transplantation 90 (1), 68-74, 2010 | 591 | 2010 |
| The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell–and antibody‐mediated rejection A Loupy, M Haas, C Roufosse, M Naesens, B Adam, M Afrouzian, ... American Journal of Transplantation 20 (9), 2318-2331, 2020 | 540 | 2020 |
| Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H) AD Kirk, DA Hale, RB Mannon, DE Kleiner, SC Hoffmann, RL Kampen, ... Transplantation 76 (1), 120-129, 2003 | 514 | 2003 |
| Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion JP Pearl, J Parris, DA Hale, SC Hoffmann, WB Bernstein, KL McCoy, ... American journal of transplantation 5 (3), 465-474, 2005 | 513 | 2005 |
| Metformin reverses established lung fibrosis in a bleomycin model S Rangarajan, NB Bone, AA Zmijewska, S Jiang, DW Park, K Bernard, ... Nature medicine 24 (8), 1121-1127, 2018 | 474 | 2018 |
| Cell-free DNA and active rejection in kidney allografts RD Bloom, JS Bromberg, ED Poggio, S Bunnapradist, AJ Langone, ... Journal of the American Society of Nephrology 28 (7), 2221-2232, 2017 | 461 | 2017 |
| Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay RJ Kowalski, DR Post, RB Mannon, A Sebastian, HI Wright, G Sigle, ... Transplantation 82 (5), 663-668, 2006 | 418 | 2006 |
| Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse C Nataraj, DW Thomas, SL Tilley, MT Nguyen, R Mannon, BH Koller, ... The Journal of clinical investigation 108 (8), 1229-1235, 2001 | 386 | 2001 |
| Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. DW Thomas, RB Mannon, PJ Mannon, A Latour, JA Oliver, M Hoffman, ... The Journal of clinical investigation 102 (11), 1994-2001, 1998 | 351 | 1998 |
| Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway C Nataraj, MI Oliverio, RB Mannon, PJ Mannon, LP Audoly, ... The Journal of clinical investigation 104 (12), 1693-1701, 1999 | 349 | 1999 |
| Sensitization in transplantation: assessment of risk (STAR) 2017 working group meeting report AR Tambur, P Campbell, FH Claas, S Feng, HM Gebel, AM Jackson, ... American Journal of Transplantation 18 (7), 1604-1614, 2018 | 238 | 2018 |
| Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure RB Mannon, AJ Matas, J Grande, R Leduc, J Connett, B Kasiske, ... American Journal of Transplantation 10 (9), 2066-2073, 2010 | 229 | 2010 |
| Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US J Sun, Q Zheng, V Madhira, AL Olex, AJ Anzalone, A Vinson, JA Singh, ... JAMA internal medicine 182 (2), 153-162, 2022 | 226 | 2022 |
| Recommended treatment for antibody-mediated rejection after kidney transplantation: the 2019 expert consensus from the transplantion society working group CA Schinstock, RB Mannon, K Budde, AS Chong, M Haas, S Knechtle, ... Transplantation 104 (5), 911-922, 2020 | 210 | 2020 |
| Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortium PA Jacobson, WS Oetting, AM Brearley, R Leduc, W Guan, D Schladt, ... Transplantation 91 (3), 300-308, 2011 | 193 | 2011 |
| Delayed graft function: the AKI of kidney transplantation RB Mannon Nephron 140 (2), 94-98, 2018 | 187 | 2018 |
Arthur Matas在 umn.edu 的电子邮件经过验证
